Silco Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2024
For the nine months, sales was BDT 317 million compared to BDT 359.86 million a year ago. Net income was BDT 40.65 million compared to BDT 67.12 million a year ago. Basic earnings per share from continuing operations was BDT 0.39 compared to BDT 0.65 a year ago.